24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
ENZALIEVA 40MG is an Capsules medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ENZALIEVA 40MG |
|---|---|
| Composition | Enzalutamide Capules 40mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Capsules |
| Packaging | Strip (4 x 28 cap) |
| Country of Origin | India |
Enzalutamide Capules 40mg (Enzalutamide Capules 40mg) is a widely used Capsules medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.
Enzalutamide is indicated for:
1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2. Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC)
3. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Used along with androgen deprivation therapy (ADT) or after surgical castration.
Common side effects:
• Fatigue
• Hot flashes
• Hypertension
• Decreased appetite
• Back pain
Neurological effects:
• Dizziness
• Headache
Serious side effects:
• Seizures (rare)
• Falls and fractures
• Posterior reversible encephalopathy syndrome (PRES – rare)
Monitor blood pressure, neurological status, and risk of fall
Standard adult dose:
• 160 mg once daily
Taken as four 40 mg capsules once daily.
• Can be taken with or without food
• Continue ADT during treatment
NOTE: This medicine should be taken only under a doctor’s supervision.